Acquired Haemophilia: Functional Study of Antibodies to Factor VIII

Summary

Factor VIII complex and its interaction with antibodies to factor VIII have been studied in 17 non-haemophilic patients with factor VIII inhibitor. Low VIII:C and high VIIIR.Ag levels were found in all patients. VIII:WF levels were 50% of those of VTIIRrAg, possibly related to an increase of poorly aggregated and electrophoretically fast moving VIIIR:Ag oligomers.

Antibody function has been characterized by kinetics of VIII :C inactivation, saturability by normal plasma and the slope of the affinity curve. Two major patterns were observed:

1) Antibodies from 6 patients behaved similarly to those from haemophiliacs by showing second order inhibition kinetics, easy saturability and steep affinity slope (> 1).

2) Antibodies from other patients, usually with lower titres, inactivated VIII :C according to complex order kinetics, were not saturable, and had a less steep affinity slope (< 0.7). In native plasma, or after mixing with factor VIII concentrate, antibodies of the second group did not form immune complexes with the whole factor VIII molecular complex. However, dissociation procedures did release some antibodies from apparently low molecular weight complexes formed in vivo or in vitro. For appropriate management of non-haemophilic patients with factor VIII inhibitor, it is important to determine the functional properties of their antibodies to factor VIII.

Keywords

Auto-immune antibodies to factor VIII - Acquired haemophilia - Kinetics of factor VIII inhibition - Factor VIII molecular complex

• References

• 1 Shapiro SS, Hultin M. Acquired inhibitors to the blood coagulation factors. Sem Thromb Haemostas 1975; 01: 336-385
• 2 Lechner K. Acquired inhibitors in non-hemophilic patients. Haemostasis 1974; 03: 65-93
• 3 Allain JP, Gaillandre A, Lee HH. Immunochemical characterization of antibodies to Factor VIII in hemophilic and non-hemophilic patients. J Lab Clin Med. 1981 in press
• 4 Soulier JP, Larrieu MJ. Nouvelle méthode de diagnostic de l’hémophilie. Dosage des facteurs anti-hémophiliques A et B. Sang 1953; 24: 205-215
• 5 Laurell CB. Electro immuno assay. Scand J Clin Lab Invest 1972; (Suppl. 24) 21-37
• 6 Meyer D, Plas A, Allain JP, Sitar GM, Larrieu MJ. Problems in the detection of carriers of haemophilia A. J Clin Pathol 1975; 28: 690-695
• 7 Allain JP, Cooper HA, Wagner RH, Brinkhous KM. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor. J Lab Clin Med 1975; 85: 318-328
• 8 Allain JP, Frommel D. Antibodies to Factor VIII: V. Patterns of immune response to Factor VIII in hemophilia A. Blood 1976; 47: 973-982
• 9 Allain JP, Frommel D. Antibodies to Factor VIII: specificity and kinetics of iso and hetero-antibodies in hemophilia A. Blood 1974; 44: 313-322
• 10 Allain JP, Frommel D. Antibodies to Factor VIII. I. Variations in stability of antigen-antibody complexes in hemophilia A. Blood 1973; 42: 437-444
• 11 Holmberg L, Nilsson IM. AHF related protein in clinical praxis. Scand J Haematol 1974; 12: 221-231
• 12 Al-Ismail SA D, Parry DH, Moisey CV, Bloom AL. Factor VIII inhibitor and bronchogenic carcinoma. Thromb Haemostas 1979; 41: 291-295
• 13 Gastaldi G, Reali G, Campanella A, Galletti A, Ferraro A. Tipizzazione immunologica di anticorpi spontanei anti-fattore VIII. La TdS 1976; 02: 130-139
• 14 Me KelveyE M, Kwaan HC. An IgM circulating anticoagulant with Factor VIII inhibitory activity. Ann Intern Med 1972; 77: 571-575
• 15 Klein KG, Parkin JD, Madatas F. Studies on an acquired inhibition of Factor VIII inducec by penicillin allergy. Clin Exp Immunol 1976; 26: 155-161
• 16 Ingram GC, Prentice CR M, Forbes CD, Leslie J. Low Factor VIII like antigen in acquired von Willebrand’s syndrome and response to treatment. Brit J Haematol 1973; 25: 137-140
• 17 Shapiro SS. The immunologic character of acquired inhibitors of antihemophilic globulin (Factor VIII) and the kinetics of their interaction with Factor VIII. J Clin Invest 1967; 46: 147-156
• 18 Biggs R, Austen DE G, Denson KW E, Rizza CR, Borrett R. The mode of action of antibodies which destroy Factor VIII. 1. Antibodies which have a second order concentration graphs. Brit J Haematol 1972; 23: 125-135
• 19 Lazarchick J, Hoyer LW. The properties of immune complexes formed by human antibodies to Factor VIII. J Clin Invest 1977; 601070-601079
• 20 Shapiro SS. Characterization of Factor VIII antibodies. Ann N Y Acad Sci 1975; 20: 350-360
• 21 Green D. Spontaneous inhibitors of Factor VIII. Brit J Haematol 1968; 15: 57-75
• 22 Biggs R, Austen DE G, Densen KWE, Borrett R, Rizza CE. The mode of action of antibodies which destroy Factor VIII, II. Antibodies which give complex concentration graphs. Brit J Haematol 1972; 23: 137-155
• 23 Kemoff PB A. The relevance of Factor VIII inactivation characteristics in the treatment of patients with antibodies directed against Factor VIII. Brit J Haematol 1971; 22: 735-742
• 24 Michiels JJ, Bosch LJ, Vander PlasP M, Abels J. Factor VIII inhibitor post-partum. Scand J Haematol 1978; 20: 97-107
• 25 Rizza CR, Biggs R. The treatment of patients who have Factor VIII antibodies. Brit J Haematol 1973; 24: 65-82